Literature DB >> 29072791

Improving the accrual of racial and ethnic minority patients in clinical trials: Time to raise the stakes.

Abiola Ibraheem1, Blase Polite1.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 29072791     DOI： 10.1002/cncr.31073

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  7 in total

Review 1.  Barriers to accrual and enrollment in brain tumor trials.

Authors:  Eudocia Q Lee; Ugonma N Chukwueke; Shawn L Hervey-Jumper; John F de Groot; Jose Pablo Leone; Terri S Armstrong; Susan M Chang; David Arons; Kathy Oliver; Kay Verble; Al Musella; Nicole Willmarth; Brian M Alexander; Amanda Bates; Lisa Doherty; Evanthia Galanis; Sarah Gaffey; Thomas Halkin; Bret E Friday; Maryam Fouladi; Nancy U Lin; David Macdonald; Minesh P Mehta; Marta Penas-Prado; Michael A Vogelbaum; Solmaz Sahebjam; David Sandak; Martin van den Bent; Michael Weller; David A Reardon; Patrick Y Wen
Journal:  Neuro Oncol       Date:  2019-09-06       Impact factor: 12.300

2.  Clinical Outcomes and Immune Markers by Race in a Phase I/II Clinical Trial of Durvalumab Concomitant with Neoadjuvant Chemotherapy in Early-Stage TNBC.

Authors:  Julia Foldi; Adriana Kahn; Andrea Silber; Tao Qing; Emily Reisenbichler; Neal Fischbach; Justin Persico; Kerin Adelson; Anamika Katoch; Anees Chagpar; Tristen Park; Adam Blanchard; Kim Blenman; David L Rimm; Lajos Pusztai
Journal:  Clin Cancer Res       Date:  2022-09-01       Impact factor: 13.801

3.  Reducing Metabolic Dysregulation in Obese Latina and/or Hispanic Breast Cancer Survivors Using Physical Activity (ROSA) Trial: A Study Protocol.

Authors:  Paola Gonzalo-Encabo; Rebekah L Wilson; Dong-Woo Kang; Mary K Norris; Hajime Uno; Cami N Christopher; Christina Chow; Nathalie Sami; Frank S Fox; Jennifer A Ligibel; Christina M Dieli-Conwright
Journal:  Front Oncol       Date:  2022-05-10       Impact factor: 5.738

4.  Positive attitudes toward clinical trials among military veterans leaves unanswered questions about poor trial accrual.

Authors:  Grace Clarke Hillyer; Yeun-Hee Anna Park; Ta-Chueh Hsu Rosenberg; Prabhjot Mundi; Imtiaz Patel; Susan E Bates
Journal:  Semin Oncol       Date:  2021-05-03       Impact factor: 4.929

5.  ARETTA: Assessing Response to Neoadjuvant Taxotere and Subcutaneous Trastuzumab in Nigerian Women With HER2-Positive Breast Cancer: A Study Protocol.

Authors:  Atara I Ntekim; Abiola Ibraheem; Adenike A Sofoluwe; Olayinka Kotila; Chinedum Babalola; Theodore Karrison; Christopher O Olopade
Journal:  JCO Glob Oncol       Date:  2020-07

6.  How current reporting practices may mask differences: A call for examining cancer-specific demographic enrollment patterns in cancer treatment clinical trials.

Authors:  Hala T Borno; Eric J Small; Li Zhang; Mindy C DeRouen; Ann Griffin; Joseph McGuire; Charles J Ryan; Robert A Hiatt; Celia P Kaplan
Journal:  Contemp Clin Trials Commun       Date:  2019-10-28

Review 7.  Physical activity, obesity and sedentary behavior in cancer etiology: epidemiologic evidence and biologic mechanisms.

Authors:  Christine M Friedenreich; Charlotte Ryder-Burbidge; Jessica McNeil
Journal:  Mol Oncol       Date:  2020-08-18       Impact factor: 6.603
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.